# Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii

> **NCT01342731** · PHASE4 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 30 (estimated)

## Conditions studied

- Antibiotic Resistant Infection

## Interventions

- **DRUG:** Tigecycline

## Key facts

- **NCT ID:** NCT01342731
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2012-06
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342731, "Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01342731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*